Physician profile
Peter Hui
NPI 1619988375
$2,800.55
in general payments reported to CMS, 2019-2025
24 companies · $250 in 2025
The $250 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,461 · 2020: $140 · 2021: $58.97 · 2022: $246 · 2023: $200 · 2024: $444 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $894.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $472.34 | 2019-2020 | |
| Medtronic, INC. | $301.67 | 2022-2025 | Symplicity G3 |
| Abiomed | $244.40 | 2019-2022 | |
| Shockwave Medical, INC | $228.44 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $220.58 | 2019-2023 | Amplatzer Talisman |
| Boston Scientific Corporation | $208.62 | 2019-2024 | Avvigo Guidance System |
| Janssen Pharmaceuticals, INC | $175.09 | 2019-2021 | |
| Astellas Pharma US INC | $146.54 | 2019 | |
| Cardiovascular Systems INC. | $138.36 | 2019 | |
| Sanofi-Aventis U.S. LLC | $117.38 | 2019 | |
| Amgen INC. | $96.55 | 2019 | |
| Philips North America LLC | $95.31 | 2019-2025 | (6585) Omniwire, (9266) Elca, Coronary Other |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.02 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.27 | 2019-2021 | |
| Lundbeck LLC | $42.08 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $35.67 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $34.75 | 2019 | |
| Stryker Corporation | $34.32 | 2025 | Artix Mt, Clottriever Bold Catheter, Flowtriever |
| Gilead Sciences, INC. | $27.30 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $22.10 | 2019 | |
| Pfizer INC. | $22.00 | 2019 | |
| Bardy Diagnostics, INC. | $20.97 | 2022 | |
| Chiesi USA, INC. | $15.79 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Hui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.